FDA Approves the First-in-Class Bispecific Antibody for Treatment of Follicular LymphomaPosted On: December 23, 2022 Read More
The Leukemia & Lymphoma Society Honors Six Outstanding Blood Cancer Scientists with 2022 Achievement AwardsPosted On: December 23, 2022 Read More
FDA Approves New Targeted Treatment Option for Certain Forms of Acute Myeloid Leukemia in AdultsPosted On: December 2, 2022 Read More
The Leukemia & Lymphoma Society Earns a Four-Star Rating From Charity NavigatorPosted On: November 16, 2022 Read More
LLS Applauds FDA Approval of New Treatment Option for Pediatric Patients with Hodgkin LymphomaPosted On: November 11, 2022 Read More
Crucial LLS Support Drives Approval of New Precision Medicine for Rare Group of Blood DiseasesPosted On: November 4, 2022 Read More
Shred For Red: An Unstoppable Community Hits the Slopes to End Blood CancerPosted On: October 31, 2022 Read More
Please send all media-related inquiries and interview requests to email@example.com. An LLS representative will respond as soon as possible.